Filing Details

Accession Number:
0001104659-20-113186
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-07 21:30:49
Reporting Period:
2020-10-05
Accepted Time:
2020-10-07 21:30:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781983 Aprea Therapeutics Inc. APRE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1240357 D John Diekman 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1589314 5Am Partners Iv, Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1589315 5Am Ventures Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1593361 5Am Co-Investors Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1598549 J. Andrew Schwab 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1664281 Kush Parmar 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1753000 5Am Opportunities I, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
1790778 5Am Opportunities I (Gp), Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-10-05 175,000 $25.30 138,497 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,823,192 Indirect See footnotes
Common Stock 75,965 Indirect See footnotes
Footnotes
  1. Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.
  2. 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.
  3. Shares are held directly by 5AM Ventures IV, L.P.
  4. 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Dr. Scott M. Rocklage and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.
  5. Shares are held directly by 5AM Co-Investors IV, L.P.